Unique immunomodulating properties of dimethyl dioctadecyl ammonium bromide (DDA) in experimental viral vaccines.
Katz
D
D
Department of Virology, Israel Institute for Biological Research, Ness-Ziona.
Lehrer
S
S
Galan
O
O
Lachmi
B
B
Cohen
S
S
Inbar
I
I
Samina
I
I
Peleg
B
B
Heller
D
D
Yadin
H
H
Chai
D
D
Freeman
E
E
Schupper
H
H
Fuchs
P
P
D000276:Adjuvants, Immunologic; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000917:Antibody Formation; D001912:Bovine Virus Diarrhea-Mucosal Disease / Q000276:immunology; D002417:Cattle; D002645:Chickens; D006968:Hypersensitivity, Delayed; D051379:Mice; D009522:Newcastle disease virus / Q000276:immunology; D000644:Quaternary Ammonium Compounds / Q000009:adverse effects / Q000633:toxicity; D011819:Rabies Vaccines; D012672:Semliki forest virus / Q000276:immunology; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D000644:Quaternary Ammonium Compounds; D011819:Rabies Vaccines; D015164:Vaccines, Inactivated; D014614:Vaccines, Synthetic; D014765:Viral Vaccines; C015831:dimethyldioctadecylammonium